Insulet

Insulet Days Sales Outstanding

The Days Sales Outstanding (DSO) of Insulet (PODD) as of Nov 20, 2026 is 69.67. In the previous year, Days Sales Outstanding (DSO) was 64.40 — a change of 8.18% (higher).

Days Sales Outstanding

69.67

YoY

8.18%

Last updated:

Days Sales Outstanding (DSO) of Insulet is 2025 69.67 . Days Sales Outstanding (DSO) of Insulet was 2024 64.40 . It decreases by 8.18% higher compared to the previous year.

The Insulet Days Sales Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Sales Outstanding
Date
Days Sales Outstanding
Jan 1, 2018
49.65 USD
Jan 1, 2019
40.94 USD
Jan 1, 2020
33.82 USD
Jan 1, 2021
53.48 USD
Jan 1, 2022
57.49 USD
Jan 1, 2023
77.36 USD
Jan 1, 2024
64.40 USD
Jan 1, 2025
69.67 USD
The Insulet Days Sales Outstanding history
YEARDays Sales OutstandingYoY
69.67+8.18%
64.40-16.76%
77.36+34.56%
57.49+7.50%
53.48+58.13%
33.82-17.39%
40.94-17.55%
49.65+18.14%
42.03+46.72%
28.64-51.27%
58.78+16.54%
50.44—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Insulet Stock analysis

What does Insulet do? Insulet Corp is an American company that was founded in 2000 and is headquartered in Acton, Massachusetts. Its goal is to improve the quality of life for people with diabetes by developing innovative products that make living with this chronic disease easier. Insulet Corp is known for its product "OmniPod." The OmniPod is a wireless, portable disposable insulin pump system that offers an alternative option to traditional pumping and insulin delivery systems. The OmniPod system consists of two small devices: a pod worn on the skin and a PDM (Personal Diabetes Manager) that regulates insulin delivery. The pod contains an insulin reservoir that communicates wirelessly with the PDM. The insulin dose is administered directly into the body without needles or tubes. Insulet Corp is also introducing the "OmniPod DASH System." This new system combines the proven design of the OmniPod pod with a new color touchscreen handheld device that allows for even easier operation. The DASH system also offers the ability to control insulin dosing from a smartphone, which can be taken with diabetics wherever they go. The success of the OmniPod system has made Insulet Corp a leading company in the diabetes industry. The company has also developed and introduced products and services in other areas of diabetes treatment. Insulet Corp has developed another product called "Amigo." This product is a personalized travel and training program for people who require insulin. Amigo offers specialized and personalized training to support diabetics in managing complex situations. It also offers diet and exercise plans to make living with diabetes easier. Insulet Corp has also developed a software called "OmniPod Horizon." This software is a closed-loop system that automatically adjusts insulin dosing to keep blood sugar levels within the target range. The system is currently in the development phase and is expected to be released in 2020. Insulet Corp has also developed a program called the "OmniPod Partner Program," which targets doctors and pharmacists. The program provides training and educational materials for healthcare providers to help them better treat and manage their patients. Since 2009, Insulet Corp has been listed on the NASDAQ stock exchange and has continuously evolved since then. The company currently has over 1500 employees and operates in North America, Europe, and the Middle East. Insulet Corp is a company focused on the development of innovative, life-changing products and services. It is expected to continue to play a significant role in improving the quality of life for people with diabetes in the future. Insulet is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Insulet stock

Days Sales Outstanding (DSO) of Insulet is 69.67 in 2025.

Days Sales Outstanding (DSO) of Insulet changed from 64.40 to 69.67, representing a 8.18% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Days Sales Outstanding (DSO) Insulet since 2006 – with annual values, charts, and detailed analysis.

DSO measures the average number of days it takes to collect payment after a sale. Lower DSO indicates faster cash collection.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Sales Outstanding (DSO)'s Insulet with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Sales Outstanding (DSO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Sales Outstanding (DSO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Insulet

All Key Metrics — Insulet